PF-07059013   Click here for help

GtoPdb Ligand ID: 12786

Synonyms: compound 23 [PMID: 33356244] | PF07059013
PDB Ligand
Compound class: Synthetic organic
Comment: PF-07059013 is an oarlly available, non-covalent hemoglobin modulator with a similar machanism of action to the approved Sickle cell anemia treatment voxelotor [1-2], i.e., it stabilises sickle cell haemoglobin (HbS) in a state with high affinity for oxygen.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 2
Rotatable bonds 4
Topological polar surface area 92.31
Molecular weight 365.36
XLogP 0.86
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C[C@@H](C1=C(C=CC(=O)N1)N2C=CC=N2)OC3=C(N)N=C4C=CC(=CC4=C3)F
Isomeric SMILES NC1=C(O[C@H](C2=C(N3C=CC=N3)C=CC(N2)=O)C)C=C4C(C=CC(F)=C4)=N1
InChI InChI=1S/C19H16FN5O2/c1-11(18-15(5-6-17(26)24-18)25-8-2-7-22-25)27-16-10-12-9-13(20)3-4-14(12)23-19(16)21/h2-11H,1H3,(H2,21,23)(H,24,26)/t11-/m0/s1
InChI Key CLEFVPILGAPOTG-NSHDSACASA-N
References
1. Gopalsamy A, Aulabaugh AE, Barakat A, Beaumont KC, Cabral S, Canterbury DP, Casimiro-Garcia A, Chang JS, Chen MZ, Choi C et al.. (2021)
PF-07059013: A Noncovalent Modulator of Hemoglobin for Treatment of Sickle Cell Disease.
J Med Chem, 64 (1): 326-342. [PMID:33356244]
2. Knee KM, Jasuja R, Barakat A, Rao D, Wenzel Z, Jasti J, Novak J, Beaumont K, Piotrowski DW, Jeffrey P et al.. (2021)
PF-07059013: A non-covalent hemoglobin modulator favorably impacts disease state in a mouse model of sickle cell disease.
Am J Hematol, 96 (8): E272-E275. [PMID:33891711]